New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management
New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management.
All Rx NSAIDs will carry a new boxed warning about GI and cardiovascular risk. You'll have to dispense a new Med Guide.
Celebrex (celecoxib) will also have a Medication Guide and boxed warning...plus clinical trial data on cardiovascular risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote